Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Solomon

Showing results (1261-1270 of 1,873) with videos related to

Pageof 188
Sort By:
Journal of Cardiac Failure|August 16, 2025
Rationale, design, and baseline characteristics of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 left ventricular assist device recipients (ENVAD-HF)Maja Cikes, Ivo Planinc, Jasper J Brugts, et al.
ESC Heart Failure|December 16, 2024
Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trialJerome Roncalli, François Roubille, Nicolas Meyer, et al.
Circulation. Heart Failure|January 30, 2025
Impaired Exercise Capacity in High-Risk Diabetic Cardiomyopathy: The ARISE-HF Cardiopulmonary Exercise Testing SubanalysisW H Wilson Tang, Yuxi Liu, Javed Butler, et al.
Circulation|September 13, 2019
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HFSenthil Selvaraj, Brian Claggett, Andrea Pozzi, et al.
JAMA|March 22, 2022
Association of Echocardiographic Measures of Left Atrial Function and Size With Incident DementiaWendy Wang, Michael J Zhang, Riccardo M Inciardi, et al.
JACC. Heart Failure|February 4, 2022
Effect of Dapagliflozin, Compared With Placebo, According to Baseline Risk in DAPA-HFKieran F Docherty, Joanne Simpson, Pardeep S Jhund, et al.
Human Mutation|July 16, 2009
The mutational spectrum of holoprosencephaly-associated changes within the SHH gene in humans predicts loss-of-function through either key structural alterations of the ligand or its altered synthesisErich Roessler, Kenia B El-Jaick, Christèle Dubourg, et al.
JACC. Heart Failure|August 27, 2021
Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart FailureJohn J V McMurray, David C Wheeler, Bergur V Stefánsson, et al.
Journal of the American College of Cardiology|December 17, 2021
Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic CardiomyopathySheila M Hegde, Steven J Lester, Scott D Solomon, et al.
JACC. Heart Failure|February 11, 2019
Income Inequality and Outcomes in Heart Failure: A Global Between-Country AnalysisPooja Dewan, Rasmus Rørth, Pardeep S Jhund, et al.
Pageof 188

Showing results (1261-1270 of 1,873) with videos related to

Sort By:
Pageof 188
Journal of Cardiac Failure|August 16, 2025
Rationale, design, and baseline characteristics of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 left ventricular assist device recipients (ENVAD-HF)Maja Cikes, Ivo Planinc, Jasper J Brugts, et al.
ESC Heart Failure|December 16, 2024
Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trialJerome Roncalli, François Roubille, Nicolas Meyer, et al.
Circulation. Heart Failure|January 30, 2025
Impaired Exercise Capacity in High-Risk Diabetic Cardiomyopathy: The ARISE-HF Cardiopulmonary Exercise Testing SubanalysisW H Wilson Tang, Yuxi Liu, Javed Butler, et al.
Circulation|September 13, 2019
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HFSenthil Selvaraj, Brian Claggett, Andrea Pozzi, et al.
JAMA|March 22, 2022
Association of Echocardiographic Measures of Left Atrial Function and Size With Incident DementiaWendy Wang, Michael J Zhang, Riccardo M Inciardi, et al.
JACC. Heart Failure|February 4, 2022
Effect of Dapagliflozin, Compared With Placebo, According to Baseline Risk in DAPA-HFKieran F Docherty, Joanne Simpson, Pardeep S Jhund, et al.
Human Mutation|July 16, 2009
The mutational spectrum of holoprosencephaly-associated changes within the SHH gene in humans predicts loss-of-function through either key structural alterations of the ligand or its altered synthesisErich Roessler, Kenia B El-Jaick, Christèle Dubourg, et al.
JACC. Heart Failure|August 27, 2021
Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart FailureJohn J V McMurray, David C Wheeler, Bergur V Stefánsson, et al.
Journal of the American College of Cardiology|December 17, 2021
Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic CardiomyopathySheila M Hegde, Steven J Lester, Scott D Solomon, et al.
JACC. Heart Failure|February 11, 2019
Income Inequality and Outcomes in Heart Failure: A Global Between-Country AnalysisPooja Dewan, Rasmus Rørth, Pardeep S Jhund, et al.
Pageof 188